Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peggy Ye

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The American Journal of Emergency Medicine|August 25, 2022
Toxicity of abortifacients: A review for physicians in the post roe eraMaryann Mazer-Amirshahi, Peggy Ye
The American Journal of Emergency Medicine|December 12, 2022
Mifepristone in the emergency department: "R U" ready?Maryann Mazer-Amirshahi, Peggy Ye
The American Journal of Emergency Medicine|November 5, 2022
Emergency contraception in the emergency departmentMaryann Mazer-Amirshahi, Peggy Ye
The American Journal of Emergency Medicine|November 6, 2022
In replyPeggy Ye, Maryann Mazer-Amirshahi
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|May 26, 2023
Keeping Safe and Effective Medications AccessibleMaryann Mazer-Amirshahi, Peggy Ye, Andrew Stolbach
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|August 7, 2023
ACMT Position Statement: Position on the Recent Judicial Challenge of U.S. Food and Drug Administration Approval of MifepristoneMaryann Mazer-Amirshahi, Andrew I Stolbach, Peggy Ye
American Journal of Obstetrics & Gynecology MFM|May 13, 2023
Decision and economic analysis of hostile abortion laws compared with supportive abortion lawsLea Nehme, Peggy Ye, Jim C Huang, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|December 12, 2024
ACMT Position Statement: Mifepristone and Misoprostol Are Not "Controlled Dangerous Substances"Maryann Mazer-Amirshahi, Peggy Ye, Diane P Calello, et al.
Archives of Sexual Behavior|May 27, 2022
Factors Associated with Intention to Initiate Pre-exposure Prophylaxis in Cisgender Women at High Behavioral Risk for HIV in Washington, D.CRachel K Scott, Shawnika J Hull, Jim C Huang, et al.
JMIR Formative Research|December 3, 2025
"The Women's PrEP Project," a Clinic-Based, Socio-Structural Intervention to Improve the Provision of Preexposure Prophylaxis for Cisgender Women: Interrupted Time Series PilotRachel Scott, Shawnika J Hull, Deanna Kerrigan, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The American Journal of Emergency Medicine|August 25, 2022
Toxicity of abortifacients: A review for physicians in the post roe eraMaryann Mazer-Amirshahi, Peggy Ye
The American Journal of Emergency Medicine|December 12, 2022
Mifepristone in the emergency department: "R U" ready?Maryann Mazer-Amirshahi, Peggy Ye
The American Journal of Emergency Medicine|November 5, 2022
Emergency contraception in the emergency departmentMaryann Mazer-Amirshahi, Peggy Ye
The American Journal of Emergency Medicine|November 6, 2022
In replyPeggy Ye, Maryann Mazer-Amirshahi
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|May 26, 2023
Keeping Safe and Effective Medications AccessibleMaryann Mazer-Amirshahi, Peggy Ye, Andrew Stolbach
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|August 7, 2023
ACMT Position Statement: Position on the Recent Judicial Challenge of U.S. Food and Drug Administration Approval of MifepristoneMaryann Mazer-Amirshahi, Andrew I Stolbach, Peggy Ye
American Journal of Obstetrics & Gynecology MFM|May 13, 2023
Decision and economic analysis of hostile abortion laws compared with supportive abortion lawsLea Nehme, Peggy Ye, Jim C Huang, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|December 12, 2024
ACMT Position Statement: Mifepristone and Misoprostol Are Not "Controlled Dangerous Substances"Maryann Mazer-Amirshahi, Peggy Ye, Diane P Calello, et al.
Archives of Sexual Behavior|May 27, 2022
Factors Associated with Intention to Initiate Pre-exposure Prophylaxis in Cisgender Women at High Behavioral Risk for HIV in Washington, D.CRachel K Scott, Shawnika J Hull, Jim C Huang, et al.
JMIR Formative Research|December 3, 2025
"The Women's PrEP Project," a Clinic-Based, Socio-Structural Intervention to Improve the Provision of Preexposure Prophylaxis for Cisgender Women: Interrupted Time Series PilotRachel Scott, Shawnika J Hull, Deanna Kerrigan, et al.
Pageof 1